Prognostic significance of temporal changes of lipid profile in COVID-19 patients

Baker, 2010, High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection, J. Infect. Dis., 201, 285, 10.1086/649560 Barman, 2020 Bruzzone, 2020, SARS-CoV-2 infection dysregulates the metabolomic and lipidomic profiles of serum, Iscience, 23, 101645, 10.1016/j.isci.2020.101645 Cao, 2019, Serum lipid metabolic derangement is associated with disease progression during chronic HBV infection, Clin. Lab., 65, 10.7754/Clin.Lab.2019.190525 Chen, 2020, Alteration of lipid profile and prognostic value of lipids on the length of hospital stay in COVID-19 pneumonia patients, Circulation, 142, A14904-A, 10.1161/circ.142.suppl_3.14904 Choi, 2020, The potential role of dyslipidemia in COVID-19 severity: an umbrella review of systematic reviews, J. Lipid Atherosclerosis, 9, 435, 10.12997/jla.2020.9.3.435 Ding, 2020, High-density lipoprotein cholesterol as a factor affecting virus clearance in covid-19 patients, Respir. Med., 175, 106218, 10.1016/j.rmed.2020.106218 Dreux, 2009, Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra-and extra-cellular domains, PLoS Pathog., 5, 10.1371/journal.ppat.1000310 Filippas-Ntekouan, 2017, Lipid testing in infectious diseases: possible role in diagnosis and prognosis, Infection, 45, 575, 10.1007/s15010-017-1022-3 Force, 2012, Acute respiratory distress syndrome, Jama, 307, 2526 Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N. Engl. J. Med., 382, 1708, 10.1056/NEJMoa2002032 Gungor, 2021, Elevated D-dimer levels on admission are associated with severity and increased risk of mortality in COVID-19: a systematic review and meta-analysis, Am. J. Emerg. Med., 39, 173, 10.1016/j.ajem.2020.09.018 Han, 2015, The role of surfactant in lung disease and host defense against pulmonary infections, Ann. Am. Thorac. Soc., 12, 765, 10.1513/AnnalsATS.201411-507FR Hashim, 2020, Population risk factors for COVID-19 mortality in 93 countries, J. Epidemiol. Glob. Health, 10, 204, 10.2991/jegh.k.200721.001 Holshue, 2020, First case of 2019 novel coronavirus in the United States, N. Engl. J. Med., 382, 929, 10.1056/NEJMoa2001191 Hsu, 2010, Viral reorganization of the secretory pathway generates distinct organelles for RNA replication, Cell, 141, 799, 10.1016/j.cell.2010.03.050 Hu, 2020 Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 Islamoglu, 2021, Facial paralysis as the only symptom of COVID-19: a prospective study, Am. J. Otolaryngol., 102956, 10.1016/j.amjoto.2021.102956 Kellum, 2012, Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury, Kidney Int. Suppl., 2, 1 Mechanick, 2020, Coronavirus and cardiometabolic syndrome: JACC focus seminar, J. Am. Coll. Cardiol., 76, 2024, 10.1016/j.jacc.2020.07.069 Shen, 2020, Proteomic and metabolomic characterization of COVID-19 patient sera, Cell, 182, 59, 10.1016/j.cell.2020.05.032 Terpos, 2020, Hematological findings and complications of COVID‐19, Am. J. Hematol., 95, 834, 10.1002/ajh.25829 Thygesen, 2019, Fourth universal definition of myocardial infarction (2018), Eur. Heart J., 40, 237, 10.1093/eurheartj/ehy462 Turgay Yıldırım, 2021, The atherogenic index of plasma as a predictor of mortality in patients with COVID-19, Heart Lung, 50, 329, 10.1016/j.hrtlng.2021.01.016 Wei, 2020, Hypolipidemia is associated with the severity of COVID-19, J. Clin. Lipidol., 14, 297, 10.1016/j.jacl.2020.04.008 Wu, 2020, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention, Jama, 323, 1239, 10.1001/jama.2020.2648 Wu, 2017, Altered lipid metabolism in recovered SARS patients twelve years after infection, Sci. Rep., 7, 1 Zhang, 2020, Liver injury in COVID-19: management and challenges, Lancet Gastroenterol. Hepatol., 5, 428, 10.1016/S2468-1253(20)30057-1